Patents by Inventor Sandra Anne Banack

Sandra Anne Banack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
    Patent number: 11974551
    Abstract: L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates for treatment, amelioration and/or prevention of protein aggregation/tangles/plaques and diseases associated with protein aggregation/tangles/plaques. In particular, treatments and uses for L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates include Alzheimer's disease (AD), Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Huntington disease (HD).
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: May 7, 2024
    Assignee: THE INSTITUTE FOR ETHNOMEDICINE
    Inventors: Paul Alan Cox, Sandra Anne Banack, Deborah C. Mash
  • L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
    Patent number: 11917986
    Abstract: L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates for treatment, amelioration and/or prevention of protein aggregation/tangles/plaques and diseases associated with protein aggregation/tangles/plaques. In particular, treatments and uses for L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates include Alzheimer's disease (AD), Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Huntington disease (HD).
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: March 5, 2024
    Assignee: THE INSTITUTE FOR ETHNOMEDICINE
    Inventors: Paul Alan Cox, Sandra Anne Banack, Deborah C. Mash
  • BLOOD INDICATORS OF ALZHEIMER'S DISEASE
    Publication number: 20220252620
    Abstract: Presented herein are methods of identifying a subject who has, or is at risk of developing Alzheimer's disease comprising determining a presence or amount of 2-aminoethyl dihydrogen phosphate or taurine in the blood, or a blood product, obtained from the subject. Also presented herein are method of preventing, treating or delaying the onset of Alzheimer's disease.
    Type: Application
    Filed: February 4, 2022
    Publication date: August 11, 2022
    Inventors: Sandra Anne BANACK, Paul Alan COX
  • Compositions comprising a metal and L-serine, and uses thereof
    Patent number: 11278512
    Abstract: Presented herein are compositions comprising L-serine, or a precursor, derivative or conjugate thereof, and a non-toxic metal, such as zinc. Compositions disclosed herein can be used for the prevention and treatment of neurodegenerative diseases, or related symptoms thereof.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: March 22, 2022
    Assignee: BRAIN CHEMISTRY LABS
    Inventors: Paul Alan Cox, Sandra Anne Banack, James S. Metcalf, Rachael Dunlop
  • L-SERINE COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS
    Publication number: 20220000082
    Abstract: L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates for treatment, amelioration and/or prevention of protein aggregation/tangles/plaques and diseases associated with protein aggregation/tangles/plaques. In particular, treatments and uses for L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates include Alzheimer's disease (AD), Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Huntington disease (HD).
    Type: Application
    Filed: July 12, 2021
    Publication date: January 6, 2022
    Inventors: Paul Alan COX, Sandra Anne BANACK, Deborah C. MASH
  • METHODS OF DETECTION AND ANALYSIS OF NUCLEIC ACID IN NEURAL-DERIVED EXOSOMES
    Publication number: 20210164051
    Abstract: Presented herein are methods of identifying a subject who has, or is at risk of developing a motor neuron disease comprising determining a presence or amount of one or more neural-derived micro-RNAs (miRNAs). Also presented herein are method of preventing, treating or delaying the onset of a motor neuron disease.
    Type: Application
    Filed: December 2, 2020
    Publication date: June 3, 2021
    Inventors: Sandra Anne BANACK, Rachael DUNLOP, Paul Alan COX
  • COMPOSITIONS COMPRISING A METAL AND L-SERINE, AND USES THEREOF
    Publication number: 20210052533
    Abstract: Presented herein are compositions comprising L-serine, or a precursor, derivative or conjugate thereof, and a non-toxic metal, such as zinc. Compositions disclosed herein can be used for the prevention and treatment of neurodegenerative diseases, or related symptoms thereof.
    Type: Application
    Filed: August 21, 2020
    Publication date: February 25, 2021
    Inventors: Paul Alan COX, Sandra Anne BANACK, James S. METCALF, Rachael DUNLOP
  • METHOD OF ENHANCING GLUCOSE LEVELS IN THE CENTRAL NERVOUS SYSTEM
    Publication number: 20190374493
    Abstract: Presented herein are compositions and uses thereof for: (i) increasing or regulating glucose concentration in a central nervous system of a subject, (ii) inhibiting or delaying cognitive decline in a subject, (iii) enhancing cognitive function in a subject, and/or (iv) treating a disease or condition associated with a decreased level of glucose in a central nervous system of a subject. In some embodiments, the compositions provided herein comprise L-serine, or a precursor, derivative or conjugate thereof.
    Type: Application
    Filed: June 7, 2019
    Publication date: December 12, 2019
    Inventors: Paul Alan COX, Sandra Anne Banack
  • L-SERINE COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS
    Publication number: 20140212893
    Abstract: L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates for treatment, amelioration and/or prevention of protein aggregation/tangles/plaques and diseases associated with protein aggregation/tangles/plaques. In particular, treatments and uses for L-serine, L-serine precursors, L-serine derivatives and L-serine conjugates include Alzheimer's disease (AD), Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Huntington disease (HD).
    Type: Application
    Filed: March 28, 2014
    Publication date: July 31, 2014
    Inventors: Paul Alan Cox, Sandra Anne Banack, Deborah C. Mash